Print this page    •   Back to Web version of article

Fixed-Dose Combination Efavirenz/Tenofovir/FTC for South Africa

By Polly Clayden

May/June 2013

After a considerable wait (and considerable campaigning), in 2012, the South African Minister of Health, announced the award of a new antiretroviral tender -- worth R5.9 billion (£406,226,800).

For the first time since the ART program began, the tender includes a triple fixed-dose combination (FDC). The FDC is efavirenz/tenofovir/FTC for first line treatment and it is anticipated that over 90% of new patients will be eligible to initiate this FDC, including pregnant women.

Source:

The Southern African Clinicians Society advice document. Fixed-dose combination for adults accessing antiretroviral therapy. SAHIVMED Vol 14, No 1 (2013).

Links to other websites are current at date of posting but not maintained.




This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/71788/fixed-dose-combination-efavirenztenofovirftc-for-s.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.